Bhaskar Anand - Mar 1, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 04:15 PM
Previous filing
Jan 4, 2023
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Award $0 +3K +12.12% $0.00 27.8K Mar 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Employee Stock Option (right-to-buy) Award $0 +6K $0.00 6K Mar 1, 2023 Class A common stock 6K $28.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent Restricted Stock Units granted with performance criteria (PSUs). On May 20, 2022, the reporting person was granted 3,000 PSUs. On March 1, 2023, based on the satisfaction of certain performance criteria, the PSUs will vest on March 15, 2023, subject to continued service through the vesting date.
F2 On May 20, 2022, the reporting person was granted an option to purchase 6,000 shares of Class A common stock. On March 1, 2023, based on the satisfaction of certain performance criteria, the options will vest on March 15, 2023, subject to continued service through the vesting date.